Abstract
Objective: Non-steroidal anti-inflammatory drugs (NSAIDs) have been consistently associated with reduced colon cancer risk. Associations with other cancer sites, particularly breast cancer, have been less consistent. This study's objective was to examine the relationship between use of non-prescription and prescription NSAIDs and breast cancer and carcinoma in situ of the breast. Methods: We analyzed data from a population-based, case–control study conducted in North Carolina between 1996 and 2000 to examine the association between NSAID use and breast cancer. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CI) separately for invasive breast cancer and carcinoma in situ of the breast. Findings: NSAID use was inversely associated with invasive breast cancer (multivariable adjusted OR = 0.4; 95% CI: 0.3–0.6). Inverse associations were apparent for both prescription and non-prescription medications, and for occasional as well as regular use of NSAIDs. Inverse associations also were observed with carcinoma in situ, however the effects were somewhat weaker. Interpretation: Our study adds to the accumulating, but somewhat inconsistent evidence that NSAIDs may reduce the risk of breast cancer. Future studies should work to define the most efficacious agents and determine whether genetic, lifestyle, or other characteristics influence their anti-carcinogenic properties.
Similar content being viewed by others
References
Baron JA,Sandler RS (2000) Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 51: 511-523.
Thun MJ,Henley SJ,Patrono C (2002) Nonsteroidal antiinflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266.
Jolly K,Cheng KK,Langman MJ (2002) NSAIDs and gastrointestinal cancer prevention. Drugs 62: 945-956.
Khuder SA,Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84: 1188-1192.
Paganini-Hill A,Chao A,Ross RK,Henderson BE (1989) Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 299: 1247-1250.
Thun MJ,Namboodiri MM,Calle EE,Flanders WD,Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327.
Egan KM,Stampfer MJ,Giovannucci E,Rosner BA,Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88: 988-993.
Langman MJS,Cheng KK,Gilman EA,Lancashire RJ (2000) Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ 320: 1642-1646.
Schreinemachers DM,Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138-146.
Harris RE,Namboodiri K,Stellman SD,Wynder EL (1995) Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev Med 24: 119-120.
Harris RE,Namboodiri KK,Farrar WB (1996) Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7: 203-205.
Harris RE,Kasbari S,Farrar WB (1999) Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 6: 71-73.
Neugut AI,Rosenberg DJ,Ahsan H, et al. (1998) Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 7: 869-873.
Coogan PF,Rao S,Rosenberg L, et al. (1999) The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med 29: 72-76.
Cotterchio M,Kreiger N,Sloan M,Steingart A (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 1213-1217.
Sharpe CR,Collet J-P,McNutt M,Belzile E,Boivin J-F,Hanley JA (2000) Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 83: 112-120.
Newman B,Moorman PG,Millikan R, et al. (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35: 51-60.
Moorman PG,Grubber JM,Millikan RC,Newman B (2003) Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology 14: 307-314.
Weinberg CR,Sandler DP (1991) Randomized recruitment in case-control studies. Am J Epidemiol 134: 421-432.
Ouellet M,Percival MD (2001) Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys 387: 273-280.
Alshafie GA,Abou-Issa HM,Seibert K,Harris RE (2000) Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model. Oncol Rep 7: 1377-1381.
Hwang D,Scollard D,Byrne J,Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90: 455-460.
Han EK,Arber N,Yamamoto H, et al. (1998) Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res Treat 48: 195-203.
Glue P,Clement RP (1999) Cytochrome P450 enzymes and drug metabolism-basic concepts and methods of assessment. Cell Mole Neurobiol 19: 309-323.
Guengerich FP (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39: 1-17.
Guillemette C,Millikan RC,Newman B,Housman DE (2000) Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African-Americans. Cancer Res 60: 950-956.
Bigler J,Whitton J,Lampe JW,Fosdick L,Bostick RM,Potter JD (2001) CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res 61: 3566-3569.
London SJ,Daly AK,Leathart JB,Navidi WC,Idle JR (1996) Lung cancer risk in relation to the CYP2C9 * 1/CYP2C9 * 2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics 6: 527-533.
Monson RA,Bond CA (1978) The accuracy of the medical record as an index of outpatient drug therapy. JAMA 240: 2182-2184.
Stolley PD,Tonascia JA,Sartwell PE, et al. (1978) Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am J Epidemiol 107: 226-235.
Cottler LB,Robins LN (1985) The effect of questionnaire design on reported prevalence of psychoactive medication. In: Harris LS, ed. Problems of Drug Dependence, 1984. NIDA Research Monograph 55, pp. 231-237.
Beresford SAA,Coker AL (1989) Pictorially assisted recall of past hormone use in case-control studies. Am J Epidemiol 130: 202-205.
Mitchell AA,Cottler LB,Shapiro S (1986) Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 123: 670-676.
Top 200 Prescription Drugs. http://rxlist.com/top200.htm, accessed December 3, 2002.
Chan TA (2002) Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol 3: 166-174.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moorman, P.G., Grubber, J.M., Millikan, R.C. et al. Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 14, 915–922 (2003). https://doi.org/10.1023/B:CACO.0000007973.59863.66
Issue Date:
DOI: https://doi.org/10.1023/B:CACO.0000007973.59863.66